Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease

Basic Research in Cardiology

Volumn 99, Issue 3, 2004, Pages 223-229

  Tamer, Lülüfer ^a   Ercan, Bahadir ^a   Camsari, Ahmet ^a   Yildirim, Hatice ^a   Çiçek, Dilek ^a   Sucu, Nehir ^a   Ateş, Nurcan Aras ^a   Atik, Uǧur ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

CAD; Cigarette smoking; GSITI; GSTM1; Polymorphism

Indexed keywords

CARCINOGEN; DNA; GLUTATHIONE TRANSFERASE; TOBACCO SMOKE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DETOXIFICATION; DISEASE ASSOCIATION; DNA DAMAGE; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SMOKING;

EID: 2342561073     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-004-0465-8     Document Type: Article

References (35)

1. D'Errico A, Malats N, Vineis P, Boffetta P (1999) Review of studies of selected metabolic polymorphisms and cancer. IARC Sci Punl 148: 323-393
2. Bell D, Taylor J, Paulson D, Robertson C, Mohler J, Lucier G (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 1159-1164
3. Bridges BA, Bowyer DE, Hansen ES, Penn A, Wakabayashi K (1990) The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1 Conclusions and recommendations. Mutat Res 239: 143-148
4. Brockmoller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyl-transferase 2, glutathione S-transferases MI and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-25
5. Chen H, Sandler DP, Taylor JA et al. (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect [see comments]. Lancet 347: 295-297
6. De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J (1997) Molecular epidemiology of atherosclerosis. FASEB J 11: 1021-1031
7. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferencial formation of benzo [a] pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430-432
8. Elexpuru-Camiruaga J, Buxton N, Kandula et al. (1995) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) Loci. Cancer Res 55: 4237-4239
9. Greenblatt, MS, Bennett, WP, Hollstein M, Harriss CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
10. Hell Ol VD, Peeters PH, Hein DW, Doll MA, Grobbee DE, Kromhout D, Bueno de Mesquita HB (2003) NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13: 399-407
11. Hemminki K, Diple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H (1994) DNA adducts: Identification and biological significance. Oxford University Pres, Oxford
12. Izzotti A I, Cartiglia C, Lewtas J, Flora SD (2001) Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. The FASEB Journal 15: 752-757
13. Izzotti A, De Flora S, Petrilli GL et al. (1995) Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol Biol Prev 4: 105-110
14. Ko Y, Koch B, Harth V et al. (2000) Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction. Pharmacogenetics 10: 1-4
15. Li R, Boerwinkle E, Olshan AF et al. (2000) Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis 149: 451-462
16. Li R, Folsom AR, Couper D, Bray M, Tyroler HA (2001) Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154: 729-738
17. Mannervik B, Awasthi YC, Board PG et al. (1992) Nomenclature for human glutathione S-transferases. Biochem J 282: 305-306
18. Marenberg ME, Risch N, Berkman LF, Floderus B, de F (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. New Eng J Med 330: 1041-1046
19. Masetti S, Botto N, Manfredi S et al. (2003) Interactive effect of glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med Jun 17
20. Maxwell SR (2000) Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 1: 165-171
21. Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B (1991) Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274: 409-414
22. Miller EA, Pankow JS, Millikan RC, Bray MS, Ballantyne CM, Bell DA, Heiss G, Li R (2003) Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 171: 265-272
23. Olshan AF, Li R, Pankow JS, Bray M, Tyroler HA, Chambless LE, Boerwinkle E, Pittman GS, Bell DA (2003) Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology. May 14 (3): 321-327
24. Pemble S, Schroeder K, Spencer S, Meyer D, Hallier H, Bollt H, Ketterer B, Taylor J (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-276
25. Penn A, Snyder C (1996) 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque. Circulation 93: 552-557
26. Penn A, Snyder C (1988) Arteriosclerotic plaque development is "promoted" by polynuclear aromatic hydrocarbons. Carcinogenesis 9: 2185-2189
27. Rosenberg L, Kaufman DW, Hemrich SP, Shapiro S (1985) The risk of myocardial infarction after quiting smoking in men under 55 years age. N Engl J Med 313: 1511-1514
28. Salama SA, Au WW, Hunter GC et al. (2002) Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environ Mol Mutagen 40 (3): 153-160
29. Seidegard J, Pero RW (1985) The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 69: 66-68
30. Van Jaarsveld H, Kuyl JM, Alberts DW (1992) Exposure of rats to low concentration of cigarette smoke increases myocardial sensitivity to ischaemia/reperfusion. Basic Res Cardiol 87 (4): 393-399
31. Van Schooten FJ, Hirvonen A, Maas LM et al. (1998) Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking and aromatic DNA adduct levels in human right atrial tissue. FASEB J 12: 1409-1417
32. Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF (2001) Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 158: 227-231
33. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE (2002) Glutathione S-transferase mul deficiency, cigarette smoking and coronary artery disease. J Cardiovac Risk 9: 25-31
34. Wilson HM, Grant JP, Hardie JL, Wild PC (2000) Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. The FASEB Journal 14: 792
35. Wilson MH, Grant PJ, Kain K, Warner DP, Wild CP (2003) Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 8: 43-50